Influence of growth hormone treatment on pubertal timing and pubertal growth in children with idiopathic short stature

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 5, 1999, Pages 611-622

  Rekers Mombarg, L T M ^a,c   Kamp, G A ^b   Massa, G G ^a   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Final height; Growth hormone treatment; Idiopathic short stature; Intra uterine growth retardation; Puberty

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PUBERTY; SCHOOL CHILD; SHORT STATURE;

EID: 0032846267     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.5.611     Document Type: Article

References (34)

1. Wit JM, Fokker MH, de Muinck Keizer-Schrama SMPF, Oostdijk W, Gons M, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJJ. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. J Pediatr 1989; 115: 720-725.
2. The Genentech Collaborative Study Group. Response to growth hormone in children with idiopathic short stature. Acta Paediatr Scand 1990; Suppl 366: 24-26.
3. Albertsson-Wikland K. Growth hormone treatment in short children - short-term and long-term effects on growth. Acta Paediatr Scand 1988; Suppl 343: 77-84.
4. Hindmarsh PC, Brook CGD. Final height of short normal children treated with growth hormone. Lancet 1996; 348: 13-16.
5. Wit JM, Boersma B, de Muinck Keizer-Schrama SMPF, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJJ, Rikken B, Massa GG. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol 1995; 42: 365-372.
6. Wit JM, Kamp GA, Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996; 39: 295-302.
7. Rekers-Mombarg LTM, Massa GG, Wit JM. Final height of short normal children treated with growth hormone. Lancet 1996; 348: 681.
8. McCaughey ES, Mulligan J, Voss LD, Betts PR. Randomised trial of growth hormone in short normal girls. Lancet 1998; 351: 940-944.
9. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD, Kaplan SL, Lippe BM, Plotnick LP, Saenger P. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993; 123: 215-222.
10. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD. Augmentation of growth hormone secretion during puberty: Evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 1987; 64: 596-601.
11. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Summary. Horm Res 1996; 45 (Suppl 2): 64-66.
12. Rekers-Mombarg LTM, Wit JM, Massa GG, Ranke MB, Buckler JM, Butenandt O, Chaussain JL, Frisch H, Leiberman E, on behalf of the European Study Group. Spontaneous growth in idiopathic short stature. Arch Dis Child 1996; 75: 175-180.
13. Kamp GA, Wit JM. High-dose growth hormone therapy in idiopathic short stature. Horm Res 1998; 49 (Suppl 2): 67-72.
14. Rekers-Mombarg LTM, Massa GG, Wit JM, Matranga AMC, Buckler JMH, Butenandt O, Chaussain JL, Frisch H, Leiberman E. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. J Pediatr 1998; 132: 455-460.
15. Roede MJ, Van Wieringen JC. Growth diagrams 1980. Netherlands third nationwide survey. Tijdsch Soc Gezondheidsz 1985; 63 (Suppl):1-34.
16. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965 part II. Arch Dis Child 1966; 41: 613-635.
17. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in seven dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969; 74: 901-910.
18. Greulich WW, Pyle SJ. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
19. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 12-23.
20. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
21. Preece MA, Baines MJ. A new family of mathematical models describing the human growth curve. Ann Hum Biol 1978; 5: 1-24.
22. Wit JM, Boersma B, de Muinck Keizer-Schrama SMPF, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJJ, Massa GG. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secteragogues. Clin Endocrinol 1995; 42: 365-372.
23. Bayley NB, Pinneau SR. Tables for predicting adult height from skeletal age. J Pediatr 1952; 40: 423-441.
24. Bourguignon JP. Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications. Endocrine Rev 1988; 9: 467-488.
25. Stanhope R, Albanese A, Hindmarsh P, Brook CGD. The effects of growth hormone therapy on spontaneous sexual development. Horm Res 1992; 38 (Suppl 1): 9-13.
26. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, Macgillivray MH. Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab 1998; 83: 1075-1079.
27. Oostdijk W. Central precocious puberty and gonadotropin releasing hormone agonist treatment. Thesis, Erasmus University, Rotterdam, 1996.
28. Adan L, Souberbielle JC, Zucker JM, Pierre-Kahn A, Kalifa C, Brauner R. Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997; 82: 229-233.
29. Chatelain P, Job JC, Blanchard J, Ducret JP, Olivier M, Sagnard L, Vanderschueren-Lodeweyckx M. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab 1994; 78: 1454-1460.
30. Spiliotis BE, August SP, Hung W, Sonis W, Mendelson W, Bereu BB. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984; 251: 2223-2230.
31. Minuto F, Barreca A, Del Monte P, Buffa C, Bevevino R, Mentale F, Torre G, Giordano G. In vivo and in vitro effect of liver on somatomedin generation. Horm Metab Res 1984; 16: 663-666.
32. Martin MM, Martin ALA, Mossman KL. Testosterone treatment of constitutional delay in growth and development: effect of dose on predicted versus definitive height. Acta Endocrinol 1986; 113 (Suppl 279): 147-152.
33. Rosenfield RL, Furlanetto RW, Bock D. Relationship of somatomedin-C concentrations to pubertal changes. J Pediatr 1983; 103: 723-728.
34. Coutant R, Carel JC, Letrait M, Bouvattier C, Chatelain P, Coste J, Chaussain JL. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 1998; 83: 1070-1074.